A detailed history of E. Ohman J:Or Asset Management Ab transactions in Cytokinetics Inc stock. As of the latest transaction made, E. Ohman J:Or Asset Management Ab holds 407,037 shares of CYTK stock, worth $15.3 Million. This represents 0.33% of its overall portfolio holdings.

Number of Shares
407,037
Previous 329,231 23.63%
Holding current value
$15.3 Million
Previous $13.2 Billion 1.64%
% of portfolio
0.33%
Previous 0.35%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2025

Jul 08, 2025

BUY
$29.84 - $42.92 $2.32 Million - $3.34 Million
77,806 Added 23.63%
407,037 $13.4 Billion
Q1 2025

Apr 11, 2025

BUY
$40.19 - $51.12 $13.2 Million - $16.8 Million
329,231 New
329,231 $13.2 Billion

Others Institutions Holding CYTK

About CYTOKINETICS INC


  • Ticker CYTK
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 94,144,096
  • Market Cap $3.55B
  • Description
  • Cytokinetics, Incorporated, a late-stage biopharmaceutical company, focuses on discovering, developing, and commercializing muscle activators and inhibitors as potential treatments for debilitating diseases. The company develops small molecule drug candidates primarily engineered to impact muscle function and contractility. Its drug candidates i...
More about CYTK
Track This Portfolio

Track E. Ohman J:Or Asset Management Ab Portfolio

Follow E. Ohman J:Or Asset Management Ab and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of E. Ohman J:Or Asset Management Ab, based on Form 13F filings with the SEC.

News

Stay updated on E. Ohman J:Or Asset Management Ab with notifications on news.